Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Although currently there are only a limited number of genomic technologies that are applicable to health care in the developing countries, this is unlikely to be the case in the near future. If, however, the full potential of genomics for health care is to be fulfilled, there will have to be a complete change of emphasis in education and research in the richer countries toward a more global view of disease and its consequences.

Original publication

DOI

10.1126/science.1089864

Type

Journal article

Journal

Science

Publication Date

24/10/2003

Volume

302

Pages

597 - 599

Keywords

Anemia, Sickle Cell, Biomedical Research, Developing Countries, Education, Medical, Genetic Techniques, Genomics, Global Health, Humans, Infection, International Cooperation, Molecular Biology, Public Health, Technology Transfer, Thalassemia, Universities